Ausgabe 2/2015
Inhalt (13 Artikel)
Appreciation for Prof. Rolf Sauer on the occasion of the transferral of the editorship of “Strahlentherapie und Onkologie”
Rainer Fietkau, Frederik Wenz
Evaluation of the time required for overhead tasks performed by physicians, medical physicists, and technicians in radiation oncology institutions
Cornelia Sack, Horst Sack, Normann Willich, Wolfgang Popp
Stereotactic body radiotherapy for centrally located stage I NSCLC
Daniel H. Schanne, Ursula Nestle, Michael Allgäuer, Nicolaus Andratschke, Steffen Appold, Ute Dieckmann, Iris Ernst, Ute Ganswindt, Anca L. Grosu, Richard Holy, Michael Molls, Meinhard Nevinny-Stickel, Sabine Semrau, Florian Sterzing, Andrea Wittig, Matthias Guckenberger
Postoperative radiotherapy of patients with thymic epithelial tumors (TET)
Matthias Felix Häfner, Falk Roeder, Florian Sterzing, David Krug, Stefan A. Koerber, Jutta Kappes, Hans Hoffmann, Alla Slynko, Jürgen Debus, Marc Bischof
3’-Deoxy-3’-[18F]-fluorothymidine PET/CT in early determination of prognosis in patients with esophageal squamous cell cancer
Haojun Chen, Yimin Li, Hua Wu, Long Sun, Qin Lin, Long Zhao, Hanxiang An
Radio(chemo)therapy for locally advanced squamous cell carcinoma of the esophagus
Arif Deniz Ordu, Carsten Nieder, Hans Geinitz, Philipp Günther Kup, Lisa Felicia Deymann, Vera Scherer, Stephanie E. Combs, Khashayar Fakhrian
Comparison of 3D and 4D Monte Carlo optimization in robotic tracking stereotactic body radiotherapy of lung cancer
Mark K.H. Chan, Rene Werner, Miriam Ayadi, Oliver Blanck
Late inflammatory and thrombotic changes in irradiated hearts of C57BL/6 wild-type and atherosclerosis-prone ApoE-deficient mice
I. Patties, J. Haagen, W. Dörr, G. Hildebrandt, A. Glasow
Targeting of EGFR and HER2 with therapeutic antibodies and siRNA
Henri Wichmann, Antje Güttler, Matthias Bache, Helge Taubert, Swetlana Rot, Jacqueline Kessler, Alexander W. Eckert, Matthias Kappler, Dirk Vordermark
Effect of dose reduction on image registration and image quality for cone-beam CT in radiotherapy
B. Loutfi-Krauss, J. Köhn, N. Blümer, K. Freundl, T. Koch, E. Kara, C. Scherf, C. Rödel, U. Ramm, J. Licher
Warum lehnen Tumorpatienten eine kurative Strahlentherapie ab?
Thomas Herrmann
Einfluss von Dosis und Fraktionierung bei der intensitätsmodulierten Rebestrahlung von Patienten mit Rezidiv eines Nasopharynxkarzinoms
Carsten Nieder
Hirnmetastasen bei pulmonalem Adenokarzinom mit EGFR-Mutation
Clemens Seidel, Rolf-Dieter Kortmann